Everolimus Shows Efficacy in Combating Endocrine Resistance in Breast Cancer
Everolimus demonstrated strong potential as an effective tool for overcoming endocrine resistance in postmenopausal women with ER-positive, HER2-negative metastatic breast cancer resistant to AI therapy.
Novel Radiation Oncology Research Makes Population Health Strategies Smarter
September 26th 2017For the past 5 years, Montefiore has been a leading Pioneer Accountable Care Organization (ACO) in CMS’ ACO program, which aims to improve the quality of care for Medicare beneficiaries while identifying ways to save healthcare dollars.